http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2735472-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-14
filingDate 1995-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79a4fe827eeaf3140cf4cf24d6eb9698
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1737bdff763343cc5f67ba00b1379b3e
publicationDate 1996-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2735472-A1
titleOfInvention 4,5-DIHYDROISOXAZOLE N-OXIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
abstract Compounds of formula (I) (CF DRAWING IN BOPI) in which R1 represents a (C1 -C4) alkyl group, R2 represents either a hydrogen atom or a -COR4 group where R4 is chosen from (C1 -C4) groups ) straight or branched alkyl, phenyl and (C1 -C4) alkylthio, or a group -SO2 R5 where R5 is a (C1 -C2) alkylphenyl group and R3 represents a group -COR6 where R6 is chosen from the groups (C1 -C4) ) alkoxy and NR7 R8 with R7 and R8 each independently representing a hydrogen atom or a (C1 -C4) alkyl group, in the form of optical or geometric isomers, pure or in the form of mixtures, as well as their addition salts with pharmaceutically acceptable acids. Therapeutic application.
priorityDate 1995-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450649535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430749150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414805462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85719141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414876869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18425722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416000185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412102129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5323650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466369380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411985344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID536604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411317858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410691858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456001950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411141410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53628009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22229349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1550470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668193

Total number of triples: 53.